Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome

被引:50
|
作者
Park, Joongkyu
Yang, Eun Jin
Yoon, Joo Heon
Chung, Kwang Chul
机构
[1] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea
[2] Yonsei Univ, Coll Med, Dept Med Sci, Seoul 120752, South Korea
[3] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea
基金
新加坡国家研究基金会;
关键词
Dyrk1A; Down syndrome; Alzheimer's disease; amyloid precursor protein; amyloid-beta; tau; apoptosis; neuronal differentiation;
D O I
10.1016/j.mcn.2007.07.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Down syndrome (DS) is the most common genetic disorder, characterized by mental retardation, congenital heart abnormalities, and susceptibility to Alzheimer's disease (AD). Brain development of DS patients is associated with elevated apoptosis and abnormal neuronal differentiation. Those key features are closely associated with Man. genes mapped within Down syndrome critical region (DSCR) on human chromosome 21. Proline-directed serine/threonine kinase, Dyrk1A. is mapped within DSCR, and involved in the control of cell growth and postembryonic neurogenesis. Despite the potential involvement of Dyrk1A in neurodegeneration, its links to AD susceptibility and the neuropathology of DS patients are not yet clearly understood. Here, we report evidence supporting the correlation between Dyrk1A and neuropathology of DS. Our results show that Dyrk1A interacts with and directly phosphorylates tau and amyloid precursor protein in immortalized hippocampal progenitor H19-7 cells. In addition, the formation of tau inclusion and the enhanced generation of beta-amyloid fragment were detected in H19-7 cells that overexpressed Dyrk1A. Furthermore, these cells show a marked increase in apoptotic cell death under conditions of serum deprivation and also exhibit defects in neuronal differentiation. These results suggest that upregulation of Dyrk1A may cause AD-like pathogenesis and abnormal neurobiological features in DS patients. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:270 / 279
页数:10
相关论文
共 50 条
  • [41] Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
    Yasushi Ogawa
    Yosuke Nonaka
    Toshiyasu Goto
    Eriko Ohnishi
    Toshiyuki Hiramatsu
    Isao Kii
    Miyo Yoshida
    Teikichi Ikura
    Hiroshi Onogi
    Hiroshi Shibuya
    Takamitsu Hosoya
    Nobutoshi Ito
    Masatoshi Hagiwara
    Nature Communications, 1
  • [42] Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
    Thu Lan Nguyen
    Duchon, Arnaud
    Manousopoulou, Antigoni
    Loaec, Nadege
    Villiers, Benoit
    Pani, Guillaume
    Karatas, Meltem
    Mechling, Anna E.
    Harsan, Laura-Adela
    Limanton, Emmanuelle
    Bazureau, Jean-Pierre
    Carreaux, Francois
    Garbiss, Spiros D.
    Meijer, Laurent
    Herault, Yann
    DISEASE MODELS & MECHANISMS, 2018, 11 (09)
  • [43] Transgenic mice overexpressing the rat minibrain gene (Dyrk1a):: implications for Down syndrome
    Dierssen, M
    Altafaj, X
    Guimerà, J
    Arbonés, M
    Estivill, X
    Fillat, C
    CYTOGENETICS AND CELL GENETICS, 1999, 86 (01): : 11 - 12
  • [44] Overexpression of Dyrk1A Causes the Defects in Synaptic Vesicle Endocytosis
    Kim, Yoonju
    Park, Joohyun
    Song, Woo-Joo
    Chang, Sunghoe
    NEUROSIGNALS, 2010, 18 (03) : 164 - 172
  • [45] The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome
    Jerzy Wegiel
    Karol Dowjat
    Wojciech Kaczmarski
    Izabela Kuchna
    Krzysztof Nowicki
    Janusz Frackowiak
    Bozena Mazur Kolecka
    Jarek Wegiel
    Wayne P. Silverman
    Barry Reisberg
    Mony deLeon
    Thomas Wisniewski
    Cheng-Xin Gong
    Fei Liu
    Tatyana Adayev
    Mo-Chou Chen-Hwang
    Yu-Wen Hwang
    Acta Neuropathologica, 2008, 116 : 391 - 407
  • [46] Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
    Stringer, Megan
    Goodlett, Charles R.
    Roper, Randall J.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2017, 5 (05): : 451 - 465
  • [47] Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
    Ogawa, Yasushi
    Nonaka, Yosuke
    Goto, Toshiyasu
    Ohnishi, Eriko
    Hiramatsu, Toshiyuki
    Kii, Isao
    Yoshida, Miyo
    Ikura, Teikichi
    Onogi, Hiroshi
    Shibuya, Hiroshi
    Hosoya, Takamitsu
    Ito, Nobutoshi
    Hagiwara, Masatoshi
    NATURE COMMUNICATIONS, 2010, 1
  • [48] DYRK1A BAC Transgenic Mouse: A New Model of Thyroid Dysgenesis in Down Syndrome
    Kariyawasam, Dulanjalee
    Rachdi, Latif
    Carre, Aurore
    Martin, Merce
    Houlier, Marine
    Janel, Nathalie
    Delabar, Jean-Maurice
    Scharfmann, Raphael
    Polak, Michel
    ENDOCRINOLOGY, 2015, 156 (03) : 1171 - 1180
  • [49] Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia
    Carey-Smith, Shannon L.
    Simad, Maryam H.
    Panchal, Kunjal
    Aya-Bonilla, Carlos
    Smolders, Hannah
    Lin, Sang
    Armitage, Jesse D.
    Nguyen, Vivien T.
    Bentley, Kathryn
    Ford, Jette
    Singh, Sajla
    Oommen, Joyce
    Laurent, Anouchka P.
    Mercher, Thomas
    Crispino, John D.
    Montgomery, Andrew P.
    Kassiou, Michael
    Besson, Thierry
    Deau, Emmanuel
    Meijer, Laurent
    Cheung, Laurence C.
    Kotecha, Rishi S.
    Malinge, Sebastien
    HAEMATOLOGICA, 2024, 109 (07) : 2309 - 2315
  • [50] Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia
    Carey-Smith, Shannon L.
    Simad, Maryam H.
    Panchal, Kunjal
    Aya-Bonilla, Carlos
    Smolders, Hannah
    Lin, Sang
    Armitage, Jesse D.
    Nguyen, Vivien T.
    Bentley, Kathryn
    Ford, Jette
    Singh, Sajla
    Oommen, Joyce
    Laurent, Anouchka P.
    Mercher, Thomas
    Crispino, John D.
    Montgomery, Andrew P.
    Kassiou, Michael
    Besson, Thierry
    Deau, Emmanuel
    Meijer, Laurent
    Cheung, Laurence C.
    Kotecha, Rishi S.
    Malinge, Sebastien
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2309 - 2315